BRIEF published on 04/11/2024 at 15:40, 2 years 5 months ago Ovation Science Expands Market Reach with Exclusive Canadian License Agreement Ovation Science Inc. Ripco Processing Canada Cannabis Market Invisicare Technology Cannabis Licensing Agreement
PRESS RELEASE published on 04/11/2024 at 15:35, 2 years 5 months ago Ovation Science Expands Market Reach with Exclusive Canadian License Agreement Ovation Science Inc. signs exclusive licensing agreement with Ripco for its topical cannabis products in Canada, expanding market presence with Invisicare® technology Ovation Science Inc. Ripco Processing Inc. Topical Cannabis Products Exclusive Licensing Agreement Invisicare
Published on 09/14/2026 at 08:02, 2 hours 52 minutes ago Southern Energy Corp. Announces Rig Release of Cotton Valley Test Well at Williamsburg
Published on 09/14/2026 at 08:00, 2 hours 54 minutes ago Caledonia Mining Corporation Plc: Capital Markets Day Update
Published on 09/14/2026 at 08:00, 2 hours 54 minutes ago Touchstone Exploration Announces Operational Update
Published on 09/12/2026 at 02:35, 2 days 8 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/14/2026 at 10:35, 19 minutes ago Fiabilis Consulting Group welcomes Aurica Capital as a new shareholder to accelerate its international growth
Published on 09/14/2026 at 10:35, 19 minutes ago VEVOR Concludes IFA Berlin 2026 Debut, Looks Ahead to Further European Expansion
Published on 09/14/2026 at 10:15, 39 minutes ago TAIWAN CRAFTS & DESIGN Returns to the International Stage
Published on 09/14/2026 at 10:00, 54 minutes ago Mallia Aesthetics Presents Data on the Role of sCD83 in Hair Growth at Third Barcelona Hair Meeting
Published on 09/14/2026 at 09:42, 1 hour 12 minutes ago A new milestone for heavy-duty transportation: EKPO unveils its next-generation NM20 stack at IAA Transportation 2026
Published on 09/11/2026 at 07:00, 3 days 3 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 15 hours ago Availability of the 2026 Interim Financial Report
